21207 ⎘
Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
COVALENT POLYMER-ANTIGEN CONJUGATED PARTICLES
#2GLYCOTARGETING THERAPEUTICS
#3PEPMIXES TO GENERATE MULTIVIRAL CTLS WITH BROAD SPECIFICITY
#4VETERINARY PRODUCT
#5COVALENT DUAL-FUNCTIONAL INHIBITORS OF PEANUT ALLERGIES
#6PSEUDO-VIRAL PARTICLES AND USES OF SAME
#7COMBINED DELIVERY OF ANTIGENS AND TOLEROGENIC SIGNALS VIA DUAL-SIZED HYDROGEL SPHERES AND MOF COMPOSITES FOR TYPE-1 DIABETES VACCINE DEVELOPMENT
#8COMPOSITIONS AND METHODS FOR TARGETING ACTIVIN SIGNALING TO TREAT CANCER
#9Assays For Detecting Peanut Allergies
#10GLYCOTARGETING THERAPEUTICS
#11SKIN MICROENVIRONMENT TARGETED DELIVERY FOR PROMOTING IMMUNE AND OTHER RESPONSES
#12COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE
#13PEANUT FORMULATIONS AND USES THEREOF
#14Tolerizing Immune Modifying Nanoparticles for Overcoming the Immunogenicity of Therapeutic Vectors and Proteins
#15METHODS FOR PREVENTING FOOD SENSITIZATION
#16SINGLE-AND MULTI-EPITOPE PEPTIDE AND MRNA VACCINES TO GENERATE TOLEROGENIC EFFECTS FOR ALLERGIC AND AUTOIMMUNE DISEASE BY TARGETING LIVER SINUSOIDAL ENDOTHELIAL CELLS
#17CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#18PEPTIDE VACCINES AGAINST INTERLEUKIN-31
#19PHOSPHOSERINE CONTAINING COMPOSITIONS FOR IMMUNE TOLERANCE INDUCTION
#20GLYCOTARGETING THERAPEUTICS
#21TOLERANCE-INDUCING CONSTRUCTS AND COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF IMMUNE DISORDERS
#22METHOD AND COMPOSITION FOR INDUCING TOLERANCE
#23COMPOSITIONS AND METHODS FOR TREATING AND SUPPRESSING ALLERGIC RESPONSES
#24SELF-ASSEMBLING NANOPARTICLES
#25MHC IB-MEDIATED AQUAPORIN 4 (AQP4)-SPECIFIC IMMUNOSUPPRESSION AS A NOVEL TREATMENT FOR NMO
#26ANTIGEN-SPECIFIC THERAPY FOR AUTOIMMUNE DISEASES
#27TOLERANCE-INDUCING CONSTRUCTS AND COMPOSITION AND THEIR USE FOR THE TREATMENT OF IMMUNE DISORDERS
#28METHOD OF INDUCING TOLERANCE TO AN ALLERGEN
#29METHODS AND COMPOSITIONS RELATED TO SYNTHETIC NANOCARRIERS WITH RAPAMYCIN IN A STABLE, SUPER-SATURATED STATE
#30DENDRITIC CELL ASGPR TARGETING IMMUNOTHERAPEUTICS FOR MULTIPLE SCLEROSIS
#31COMPOSITION FOR CYTOTOXIC T CELL DEPLETION
#32CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#33PEPTIDE CONJUGATED PARTICLES
#34Peptide Conjugated Particles
#35NOVEL IMMUNOTHERAPEUTIC COMPOSITION AND USES THEREOF
#36TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) WITH TOLERIZING NANOPARTICLES
#37METHOD FOR PRODUCING AN ANTI-LAG-3 ANTIBODY
#38Immunomodulatory Combinations of Antigen and Drug-Lipid Conjugate
#39IMMUNOTHERAPEUTIC METHOD FOR INCREASING CASHEW TOLERANCE IN A SUBJECT
#40TISSUE-DIRECTED ANTIBODIES AND METHODS OF USING THE SAME
#41MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF
#42NOVEL COMBINATIONS FOR ANTIGEN BASED THERAPY
#43IMMUNOMODULATION FOR THE LONG TERM PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES AND FOREIGN TISSUE REJECTION
#44METHOD AND COMPOSITION FOR INDUCING TOLERANCE
#45METHODS OF TREATING AUTOIMMUNE DISEASE
#46Self-Assembling Nanoparticles
#47TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY
#48METHODS AND PLATFORMS FOR PROMOTING ANTIGEN-SPECIFIC TOLERANCE IN THE TREATMENT OF TYPE 1 DIABETES AND GRAFT REJECTION AND COMPOSITIONS RELATING THERETO
#49KIT AND METHOD FOR ADMINISTERING AN ACTIVE INGREDIENT TO ELICIT A PHYSIOLOGICAL RESPONSE
#50ENGINEERED Fc CONSTRUCTS
#51TREATMENT OF PEANUT ALLERGY WITH TOLERIZING NANOPARTICLES
#52TOLEROGENIC SYNTHETIC NANOCARRIERS
#53SKIN MICROENVIRONMENT TARGETED DELIVERY FOR PROMOTING IMMUNE AND OTHER RESPONSES
#54Peptide
#55COMPOSITION FOR IMMUNE TOLERANCE INDUCTION AND USE IN GENE THERAPY
#56PEPTIDE CONJUGATED PARTICLES
#57METHODS AND COMPOSITIONS FOR TREATMENT OF IMMUNE-MEDIATED DISEASES
#58NANOEMULSION VACCINE COMPOSITIONS AND METHODS FOR SUPPRESSING REACTIVITY TO MULTIPLE FOOD ALLERGENS
#59HUMAN IGE MONOCLONAL ANTIBODIES TO ANTIBODIES TO ALPHA-GAL (GALACTOSE-A-1,3-GALACTOSE) AND USES THEREFOR
#60ALLERGEN PREPARATION
#61METHODS OF TREATING HYPERGLYCEMIA AND SUPPRESSING ONSET OF TYPE 1 DIABETES
#62COMPOSITIONS OF EMBEDDED EPITOPE RANDOM PEPTIDES (EERP) FOR TREATMENT OF IMMUNE-MEDIATED CONDITIONS, AND METHODS OF USE
#63AAV-BASED GENE THERAPY FOR MULTIPLE SCLEROSIS
#64Pharmaceutical Composition For Allergen Specific Immunotherapy
#65MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereof
#66COVALENT POLYMER-ANTIGEN CONJUGATED PARTICLES
#67TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS
#68TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES
#69TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY
#70SUPPRESSION OF DIABETES USING EXOSOMES FROM STEM CELL PROGRAMMED MYELOID CELLS
#71Methods for reducing eosinophilic infiltration by administering an anti-interleukin-4 receptor (IL4R) antibody
#72THERAPEUTIC EFFICACY BY PULMONARY DELIVERY OF LIVE ATTENUATED MYCOBACTERIA
#73NOVEL METHOD
#74GLYCOTARGETING THERAPEUTICS
#75EXTRACELLULAR VESICLES FOR TREATING NEUROLOGICAL DISORDERS
#76GLYCOTARGETING THERAPEUTICS
#77GLYCOTARGETING THERAPEUTICS
#78Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response
#79SECRETABLE PROTEIN INDUCED IMMUNE TOLERIZATION AND TREATMENT OF AUTOIMMUNE, ALLERGIC AND OTHER DISEASES AND DISORDERS
#80METHOD OF DETERMINING THE IDENTITY AND/OR AMOUNT OF AN ANTI-IL-31 ANTIBODY IN A SAMPLE
#81METHODS FOR PROVIDING POLYMERIC SYNTHETIC NANOCARRIERS FOR GENERATING ANTIGEN-SPECIFIC TOLERANCE IMMUNE RESPONSES
#82PRODUCTION OF MHC II/CII COMPLEXES
#83Immunotherapeutic composition and uses thereof
#84SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION
#85Engineered Fc constructs
#86Pepmixes to generate multiviral CTLS with broad specificity
#87ANTI-CD137 ANTIBODIES AND METHODS OF USE THEREOF
#88Method and system for protecting monarch butterflies from pesticides
#89METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INDUCING IMMUNE TOLERANCE BY MUCOSAL VACCINATION WITH FC-COUPLED ANTIGENS
#90THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER
#91Compositions and methods for targeting activin signaling to treat cancer
#92ISOLATED MHC-DERIVED HUMAN PEPTIDES AND USES THEREOF FOR STIMULATING AND ACTIVATING THE SUPPRESSIVE FUNCTION OF CD8+CD45RCLOW TREGS
#93Dendritic cell ASGPR targeting immunotherapeutics for multiple sclerosis
#94IMMUNOMODULATORY PHARMACEUTICAL COMPOSITIONS INCLUDING A SYNTHETIC PEPTIDE AND TRANSFORMING GROWTH FACTOR BETA
#95METHODS, DEVICE AND REAGENTS TO TREAT ALLERGY AND AUTOIMMUNE DISEASE
#96METHODS FOR MAKING MIXED ALLERGEN COMPOSITIONS
#97Peptide
#98PEPTIDE CONJUGATED PARTICLES
#99NOVEL COMBINATIONS FOR ANTIGEN BASED THERAPY
#100Peptide conjugated particles
#101MODULATION OF ANTIGEN IMMUNOGENICITY BY DELETING EPITOPES RECOGNIZED BY NKT CELLS
#102PHOSPHOSERINE CONTAINING COMPOSITIONS FOR IMMUNE TOLERANCE INDUCTION
#103Pepmixes to generate multiviral CTLs with broad specificity
#104ALUMINUM BASED ADJUVANTS FOR TOLEROGENIC VACCINATION
#105Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response
#106APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS
#107Method and system for protecting honey bees from pesticides
#108COMPOSITIONS AND METHODS FOR TREATING AN INFLAMMATORY DISEASE OR DISORDER
#109INTRACELLULAR DELIVERY OF BIOMOLECULES TO INDUCE TOLERANCE
#110Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
#111IGE EPITOPE-LIKE PEPTIDES AND USES THEREOF
#112Anti-CD137 antibodies and methods of use thereof
#113Composition and method for reducing allergic response
#114Peanut formulations and uses thereof
#115Methods and Compositions for the Treatment of Autoimmune and Inflammatory Diseases
#116METHODS OF INDUCING IMMUNE TOLERANCE AND REDUCING ANTI-DRUG ANTIBODY RESPONSE
#117Immunomodulatory pharmaceutical compositions including a synthetic peptide and transforming growth factor beta
#118Methods of treating eosinophilic esophagitis by administering an antibody which inhibits interleukin-4 receptor (IL-4R)
#119Peptide conjugated particles
#120Peptide conjugated particles
#121DNA VACCINES AND METHODS FOR THE PREVENTION OF TRANSPLANTATION REJECTION
#122Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor
#123Composition, A Treatment Method and An Application Thereof
#124Method and system for protecting honey bees from pesticides
#125Method for depleting cytotoxic T cells using an anti-LAG-3 antibody composition
#126APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS
#127ANTI-TLR4 ANTIBODIES AND USES THEREOF
#128CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#129METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INDUCING IMMUNE TOLERANCE BY MUCOSAL VACCINATION WITH FC-COUPLED ANTIGENS
#130Compositions and methods for preventing and treating graft versus host disease
#131Combination Therapy of Acellular Pro-Tolerogenic and Pro-Inflammatory Preparations for Modulating the Immune System
#132AAV-BASED GENE THERAPY FOR MULTIPLE SCLEROSIS
#133Glycotargeting therapeutics
#134METHODS FOR EFFECTIVELY AND RAPIDLY DESENSITIZING ALLERGIC PATIENTS
#135Glycotargeting therapeutics
#136Glycotargeting therapeutics
#137Composition and method for reducing allergic response
#138CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#139TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T CELLS
#140TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF T EFFECTOR CELLS
#141METHODS OF TREATING A MAMMAL SUFFERING FROM OR SUSCEPTIBLE TO AN IMMUNE REACTION TO DRUG TREATMENT
#142METHODS AND COMPOSITIONS OF TREATING AUTOIMMUNE DISEASES
#143Compositions and Methods for Antigen-Specific Tolerance
#144Engineered Fc constructs
#145Immunomodulatory pharmaceutical compositions
#146Covalent polymer-antigen conjugated particles
#147Peptide vaccines against interleukin-31
#148SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION
#149PEPTIDE
#150Peptide conjugated particles for the treatment of inflammation
#151METHODS AND REAGENTS TO TREAT AUTOIMMUNE DISEASES AND ALLERGY
#152Methods for treating autoimmune diseases incorporating an anti-LAG3 antibody
#153Peanut formulations and used thereof
#154PROGRAMMING OF CELLS FOR TOLEROGENIC THERAPIES
#155Peanut formulations and uses thereof
#156Composition and method for reducing allergic response
#157Phosphoserine containing compositions for immune tolerance induction
#158Method and system for protecting honey bees from fipronil pesticides
#159Treatment of peanut allergy
#160COMPOSITIONS CONTAINING COMBINATIONS OF BIOACTIVE MOLECULES DERIVED FROM MICROBIOTA FOR TREATMENT OF DISEASE
#161Method for vaccination against a self-antigen in a human patient
#162TOFACITINIB AS VACCINATION IMMUNE MODULATOR
#163Compositions and methods for treating an inflammatory disease or disorder
#164Compositions and methods for targeting activin signaling to treat cancer
#165Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
#166METHODS AND COMPOSITIONS FOR ATTENUATING GENE EXPRESSION MODULATING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES
#167METHOD OF INDUCING TOLERANCE TO AN ALLERGEN
#168Methods for treating active eosinophilic esophagitis
#169Skin microenvironment targeted delivery for promoting immune and other responses
#170Therapeutic and diagnostic methods for cancer
#171Anti-CD137 antibodies and methods of use thereof
#172MODIFIED ANTIBODIES
#173Immunomodulation for the long term prevention and treatment of autoimmune diseases and foreign tissue rejection
#174Glycotargeting therapeutics
#175Aluminum based adjuvants for tolerogenic vaccination
#176Peptide conjugated particles
#177Thyroid stimulating hormone receptor peptides and uses thereof
#178Compositions comprising bacterial strains
#179TOLERANCE THERAPEUTIC FOR TREATING POLYPEPTIDE INDUCED ALLERGY
#180Assay for the diagnosis of peanut allergy
#181Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
#182Methods and pharmaceutical compositions for inducing immune tolerance by mucosal vaccination with Fc-coupled antigens
#183Process for producing an allergen extract
#184Process for Producing an Allergen Extract
#185Pepmixes to generate multiviral CTLs with broad specificity
#186Nanoparticle-Based Antigen Specific Immunotherapy
#187PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC REACTIONS
#188Tolerogenic DNA Vaccine
#189Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor
#190Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor
#191METHOD FOR INHIBITING LYMPHANGIOGENESIS BY ADMINISTRATION OF AN INHIBITOR OF THE CXCL12 PATHWAY
#192MATRIX-EMBEDDED TOLERANCE-PROMOTING ADJUVANTS FOR SUBCUTANEOUS IMMUNOTHERAPY
#193TOLEROGENIC NANOPARTICLES FOR TREATING DIABETES MELLITUS
#194Polyelectrolyte multilayers assembled from immune signal compounds
#195Baby food products containing allergenic proteins and methods of delivering same
#196COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE
#197Nucleic acids for treatment of allergies
#198Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cells
#199Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
#200COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING GRAFT VERSUS HOST DISEASE
#201TOLEROGENIC COMPOSITIONS AND METHODS
#202Gas-filled microvesicles for use as vaccine
#203FcRn-TARGETED ANTIGEN FUSION PROTEINS
#204USE OF SUPERANTIGENS FOR IMPROVING MUCOSAL ALLERGEN SPECIFIC IMMUNOTHERAPY IN HUMAN BEINGS
#205Protein-Coupled Red Blood Cell Compositions and Methods of Their Use
#206Cytokines and neuroantigens for treatment of immune disorders
#207Peptide conjugated particles
#208NUCLEIC ACIDS FOR TREATMENT OF PEANUT ALLERGIES
#209GLYCOTARGETING THERAPEUTICS
#210Anti-TLR4 antibodies and uses thereof
#211Peptide conjugated particles
#212PROTEIN-CHAPERONED T-CELL VACCINES
#213IMMUNE MODULATION FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#214METHODS OF DIAGNOSIS AND TREATMENT OF CELIAC DISEASE IN CHILDREN
#215AN ANTI-CD45RC ANTIBODY FOR USE AS DRUG
#216Methods for effectively and rapidly desensitizing allergic patients
#217METHOD FOR PRODUCING AUTOLOGOUS TOLEROGENIC DENDRITIC CELLS (TOLDCS) WITH SPECIFIC ANTIGENS AND THEIR USE IN THE PREPARATION OF A MEDICAMENT USEFUL FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
#218NOVEL COMBINATIONS FOR ANTIGEN BASED THERAPY
#219USE OF LEUKOCYTES AND NOVEL BIOMARKERS IN THE DIAGNOSIS, CONFIRMATION, AND TREATMENT OF A NEUROLOGICAL DISORDER
#220Local engineering of the lymph node environment to promote immune tolerance
#221Isolated donor MHC-derived peptide and uses thereof
#222Synergistic nutritional compositions and uses thereof
#223COMPOSITION OF ALLERGEN EXTRACTS HAVING REDUCED TOXICITY AND METHOD OF PRODUCTION THEREOF
#224Compositions comprising bacterial strains
#225USING B-CELL-TARGETING ANTIGEN IGG FUSION AS TOLEROGENIC PROTEIN THERAPY FOR TREATING ADVERSE IMMUNE RESPONSES
#226Induction of mucosal tolerance to antigens
#227Modular antigen transportation molecules and uses thereof in animals
#228HIGHLY SOLUBLE AQUAPORIN-4 EXTRACELLULAR LOOP C PEPTIDE IMMUNIZATION FOR TREATMENT OF NEUROMYELITIS OPTICA
#229SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION
#230AAV-BASED GENE THERAPY FOR MULTIPLE SCLEROSIS
#231METHODS OF EXPANDING EX VIVO NATURAL KILLER T (NKT) CELLS AND THERAPEUTIC USES THEREOF
#232DNA vaccines and methods for the prevention of transplantation rejection
#233Cancer Therapy
#234Peanut formulations and uses thereof
#235Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
#236Isolated donor MHC-derived peptide and uses thereof
#237Replacement gene tolerizing vectors and methods of use thereof
#238Compositions and methods for preparing a subject for organ or non-organ implantation
#239NOVEL TREATMENT METHOD
#240Glycotargeting therapeutics
#241Tolerogenic compositions comprising and uses thereof
#242Immunotherapeutic composition and uses thereof
#243Newly identified peptides for use in the induction of oral tolerance in young mammals
#244Histamine releaser contained in human sweat
#245Mimotopes of tropomyosin for use in immunotherapy for shellfish and/or arthropod allergy
#246CARBOHYDRATE-MODIFIED PARTICLES AND PARTICULATE FORMULATIONS FOR MODULATING AN IMMUNE RESPONSE
#247ANTIGEN-SPECIFIC IMMUNOTHERAPY USING TOLERIZING LIPOSOMES
#248Liposome-based immunotherapy
#249Treatment of celiac disease, C. difficile infection, food intolerance and food allergy with secretory IgA/IgM
#250Bacterial compositions and methods of use thereof for treatment of immune system disorders
#251Programming of cells for tolerogenic therapies
#252Aquaporin tolerizing vaccines and methods of use thereof
#253DENDRITIC CELL ASGPR TARGETING IMMUNOTHERAPEUTICS FOR MULTIPLE SCLEROSIS
#254METHOD FOR RESTORING IMMUNE TOLERANCE IN VIVO
#255Tolerogenic synthetic nanocarriers for allergy therapy
#256Use of vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals
#257Tolerogenic synthetic nanocarriers
#258Glycotargeting therapeutics
#259COMPOSITIONS AND METHODS RELATED TO OAT SENSITIVITY
#260Method of inducing tolerance to an allergen
#261MANAGING IMMUNE RESPONSES IN TRANSPLANTATION
#262METHODS OF MODULATING THE NEGATIVE CHEMOTAXIS OF IMMUNE CELLS
#263APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS
#264Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor
#265Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
#266Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
#267VACCINE PEPTIDE COMBINATIONS AGAINST CAT ALLERGY
#268Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and HLA-E-bearing composition
#269Horse allergen and methods
#270Aquaporin-4 Peptide Compositions and Methods of Use
#271Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses
#272USE OF ZEBURALINE FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR IMMUNE REJECTION OF TRANSPLANTS
#273Methods and compositions for attenuating anti-viral transfer vector immune responses
#274Methods and compositions of treating autoimmune diseases
#275Parasitic biological agents for treatment and prevention of graft versus host disease
#276COMPOSITIONS AND METHODS FOR IMMUNE TOLERANCE INDUCTION TO FACTOR VIII REPLACEMENT THERAPIES IN SUBJECTS WITH HEMOPHILIA A
#277Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
#278Compositions for treatment and/or prevention of autoimmune disorders
#279TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE CYTOTOXIC T LYMPHOCYTE RESPONSES
#280Human CTLA4 mutants and use thereof
#281Glycotargeting therapeutics
#282Local engineering of the lymph node environment to promote immune tolerance
#283TOLEROGENIC SYNTHETIC NANOCARRIERS FOR T-CELL-MEDIATED AUTOIMMUNE DISEASE
#284PEPTIDE
#285TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS
#286Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
#287TOLEROGENIC SYNTHETIC NANOCARRIERS FOR INDUCING REGULATORY B CELLS
#288Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
#289TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES
#290Process for producing an allergen extract
#291MODIFIED FVIII APITOPE PEPTIDES
#292Induction of antigen-specific tolerance by peripheral phagocytosis
#293Peptide conjugated particles
#294Regulatory T cell epitope and hepatitis C virus homolog
#295Depletion of cancer stem cells
#296Compositions and methods relating to the treatment of diseases involving TH1 and TH2/TH17
#297Method for inducing immune tolerance using non-proliferative polymer-modified allogeneic leukocytes
#298Peptide conjugated particles for the treatment of allergy
#299IgE peptide vaccine
#300Immunoregulatory vaccine